BRN brainchip holdings ltd

0.00%

20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-245

First 245 Last

Share
Profile

Follow
Zacsydney

4,062 Posts.

834

28/02/25

23:27

Post #: 78086234
Share

Originally posted by Rgupta11in: ↑

i agree with you FF and as a matter of fact most of the holders treat US listing as good step
But can we believe on the present management. The way they acted in last three days only proves they donot deserve a position in brn board.
Like keep on selling on market for almost a year and half and inbetween a big credit raise, then putting that notice of Anil selling his shares and now moving to US without any revenue on balance sheet.
it looks like we donot down rampers but own management is sufficient for that
Since the tune Sean joined we are more in trouble than flourishing
Moving to US in these conditions may suit more the management than the holders.
I assume Sean should take responsibility for failure of his policy and leave the position open for someone else to handle or show us some results before next AGM.
Upto last year they were saying we are happy with asx. Then they extended the contract with LDA as well and then they realized the Trump world and put all the holders under Trainwreck in couple of days.
Sean told us 2024 will be out year, then 2025 and now our of nowhere moving to US

If the technology is really that good then to my imagination other countries along with Australia will try to stop the move as well.
dyor

Expand

Trust must be regained. I am a holder but have lost faith and trust in management.

Why did the board release all this news at once? I am sure they could have timed the announcements better.

So many negative catalysts released in a short timeframe - truly incompetent. Share price only 3 days ago 31.5 and today 21 cents.

LDA will most likely put more downwards pressure on the share price.

Last edited by Zacsydney: 28/02/25

BRN Price at posting: 21.0¢ Sentiment: None Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 245 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 20.0¢		Change 0.000(0.00%)		Mkt cap ! $405.0M

Open	High	Low	Value	Volume
20.5¢	21.0¢	20.0¢	$1.544M	7.615M

Buyers (Bids)

No.	Vol.	Price($)
3	61852	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	217258	9

View Market Depth

No.	Vol.	Price($)
2	32537	0.200
25	968327	0.195
38	1574473	0.190
40	1943108	0.185
65	1281316	0.180

Price($)	Vol.	No.
0.205	179258	6
0.210	1653584	26
0.215	846002	16
0.220	1267378	34
0.225	840448	18

Last trade - 16.20pm 27/06/2025 (20 minute delay)

BRN (ASX) Chart

Ann: BrainChip Evaluates Redomiciling to US, page-245

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: BrainChip Evaluates Redomiciling to US, page-245

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News